|
|
Volumn 21, Issue 2, 1998, Pages 113-115
|
|
Should we purge?
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 HYDROPEROXYCYCLOPHOSPHAMIDE;
CD34 ANTIGEN;
MAFOSFAMIDE;
ACUTE GRANULOCYTIC LEUKEMIA;
AUTOTRANSPLANTATION;
BONE MARROW PURGING;
CANCER CELL;
CANCER RECURRENCE;
CANCER SURVIVAL;
COST;
EDITORIAL;
HEMATOPOIESIS;
HUMAN;
HUMAN CELL;
MAJOR CLINICAL STUDY;
MINIMAL RESIDUAL DISEASE;
MULTIPLE MYELOMA;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
STEM CELL;
STEM CELL TRANSPLANTATION;
T LYMPHOCYTE;
TREATMENT FAILURE;
|
|
EID: 0031973403
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bmt.1701051 Document Type: Editorial |
|
Times cited : (41)
|
|
References (31)
|
